论文部分内容阅读
目的:观察乳酸菌片联合复方胃蛋白酶散治疗小儿肺炎继发性腹泻的临床疗效。方法:将178例肺炎继发性腹泻患儿按月龄分为两组:1—18个月龄I组,19—36个月龄为II组。I、II组再随机分别分成治疗组和对照组。对照组在常规治疗的基础上口服乳酸菌片,治疗组在常规治疗的基础上服用乳酸菌片和复方胃蛋白酶散。结果:将I组和II组中的治疗组和对照组的疗效比较,I组中治疗组的总有效率明显高于对照组,服药期间两组均未出现不良反应。结论:乳酸菌片联合复方胃蛋白酶散可达到优势互补的效果,且具有口感好、患儿和家属易接受、疗效好、安全及无不良反应等优点,尤其对1—18个月小儿的疗效显著,值得推广。
Objective: To observe the clinical efficacy of lactic acid bacteria combined with compound pepsin in treating secondary diarrhea in children with pneumonia. Methods: A total of 178 children with secondary pneumonia secondary to diarrhea were divided into two groups according to age: Group I (1-18 months), Group II (Age 19-36). Groups I and II were randomly divided into treatment group and control group. The control group received lactic acid bacteria tablets on the basis of routine treatment. The treatment group took lactic acid bacteria tablets and compound pepsin powder on the basis of routine treatment. Results: Compared the curative effect between treatment group and control group in group I and group II, the total effective rate of treatment group in group I was significantly higher than that in control group, and no adverse reactions occurred in both groups during the treatment. Conclusion: Lactobacillus combined with compound pepsin can achieve the effect of complementarity and has the advantages of good taste, easy acceptance in children and their families, good curative effect, safety and no adverse reaction, especially for children aged 1-18 months , Worth promoting.